Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,327.00
+7.40 (0.22%)
Nov 12, 2026, 3:29 PM IST
Ajanta Pharma Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Ajanta Pharma stock has a consensus rating of "Buy" and an average price target of ₹3,866. The average 1-year stock price forecast is 16.19% higher than the current stock price, while the lowest is ₹3,109 (-6.55%) and the highest is ₹4,330 (+30.15%).
Price Target: ₹3,866 (+16.19%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ajanta Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 10 | 10 | 10 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 2 | 2 | 2 | 3 |
| Sell | 2 | 2 | 1 | 1 | 1 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Financial Forecast
Revenue This Year
64.02B
from 54.53B
Increased by 17.40%
Revenue Next Year
71.82B
from 64.02B
Increased by 12.19%
EPS This Year
102.54
from 84.51
Increased by 21.33%
EPS Next Year
117.60
from 102.54
Increased by 14.69%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.